Table 9.

Greatest relative decrease in exposure between 2005 and 2010 in ELBW infants (≥1/1000 infant exposures in 2005)

Rank	Medication	% Change	Exposure (2005)*	Exposure (2010)*
1	Cromolyn	−93	2.7	0.2
2	Terbutaline	−88	3.4	0.4
3	Scopolamine	−87	4.5	0.6
4	Norepinephrine	−85	1.3	0.2
5	Metoclopramide	−79	298	62
6	Ceftizoxime	−75	1.6	0.4
7	Aztreonam	−74	3.8	1.0
8	Theophylline	−73	38	10
9	Doxapram	−70	22	6.7
10	Chlorpromazine	−69	1.3	0.4

^*Per 1000 infants.